Oculogica

Oculogica®'s EyeBOX® device is the
only non-invasive and baseline-free
test authorized by FDA as an aid in
the diagnosis of concussion.

BREAKING NEWS: FDA grants EyeBOX device marketing authorization, making it the first non-invasive, baseline-free aid in diagnosis of concussion.

READ MORE →

EyeBOX Concussion Assessment

The EyeBOX device is easy to use. In under 4 minutes, Oculogica’s proprietary technology collects and analyzes over 100,000 data points to generate an objective assessment that is unique to each patient.

The EyeBOX device heralds a new era for concussion assessment: one that is baseline-free, objective and personalized, and available to all levels of literacy, in any language.

Oculogica

Baseline-free

Proprietary EyeBOX technology generates a quick assessment without the need for a baseline test. Results, therefore, cannot be influenced or “gamed” by the patient.

Objective

The EyeBOX test is the first FDA authorized non-invasive, objective aid in diagnosis of concussion. Its technology is based on research relating cranial nerve function to eye movements, not subjective patient symptoms.

Oculogica

Easy to Use

The EyeBOX test has no literacy or language fluency requirements. Pre-verbal and verbally impaired patients can be assessed by the EyeBOX device.